I 

116TH CONGRESS 

1ST SESSION H. R. 2676 

To direct the Secretary of Veterans Affairs to seek to enter into an agreement 

with a federally funded research and development center to conduct 

surveys to measure cannabis use by veterans, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 10, 2019 

Mr. MOULTON (for himself, Mr. GAETZ, Mr. SOTO, Mr. JOHNSON of Georgia, 

and Mr. CRIST) introduced the following bill; which was referred to the 

Committee on Veterans’ Affairs 

A BILL 

To direct the Secretary of Veterans Affairs to seek to enter 

into an agreement with a federally funded research and 

development center to conduct surveys to measure cannabis use by veterans, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘VA Survey of Cannabis 

5 Use Act’’. 

6 SEC. 2. SURVEY ON CANNABIS USE BY VETERANS. 

7 (a) IN GENERAL.—The Secretary of Veterans Affairs 

8 shall seek to enter into an agreement with a federally 


SSpencer on DSKBBXCHB2PROD with BILLS
2 

•HR 2676 IH

1 funded research and development center to conduct sur2 veys nationwide to measure cannabis use by veterans. 

3 (b) SELECTION.—The Secretary shall select a feder4 ally funded research and development center under sub5 section (a) from among such centers that have— 

6 (1) expertise and a record of independent, peer7 reviewed publications with respect to— 

8 (A) behavioral health research; and 

9 (B) conducting independent evaluations of 

10 mental health programs using multidisciplinary 

11 methods; and 

12 (2) an in-depth knowledge of all State medicinal 

13 marijuana programs and the ability to tailor the sur14 veys under subsection (a) accordingly. 

15 (c) CONDUCT OF SURVEYS.—The surveys conducted 

16 under subsection (a) shall meet the following criteria: 

17 (1) One survey shall collect information from 

18 veterans who use cannabis, including both veterans 

19 enrolled in the health care system established under 

20 section 1705(a) of title 38, United States Code, and 

21 veterans who are not so enrolled. 

22 (2) One survey shall collect information from 

23 health care providers of the Department of Veterans 

24 Affairs. 


SSpencer on DSKBBXCHB2PROD with BILLS
3 

•HR 2676 IH

1 (3) Each survey shall be conducted in a manner 

2 that ensures the anonymity of the individual being 

3 surveyed. 

4 (d) MATTERS SURVEYED.— 

5 (1) VETERANS.—The survey described in sub6 section (c)(1) shall cover the following subjects: 

7 (A) The current medicinal cannabis use by 

8 the veteran, or the intent or desire by the vet9 eran to use medicinal cannabis, and the reasons 

10 for such use, intent, or desire. 

11 (B) The conditions, symptoms, or both, 

12 that the veteran uses cannabis to treat. 

13 (C) The types of cannabis and cannabis 

14 products used by the veteran, including with re15 spect to— 

16 (i) tetrahydrocannabinol or cannabidi17 ol content; 

18 (ii) indica, sativa, mixes, or hybrids; 

19 and 

20 (iii) flower, oils, hash or kief, con21 centrates (wax, shatter, budder), edibles, 

22 drinks, tinctures, and topical ointments. 

23 (D) Other medications taken by the vet24 eran concurrently with cannabis and any mediVerDate Sep 11 2014 00:27 May 22, 2019 Jkt 089200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H2676.IH H2676

SSpencer on DSKBBXCHB2PROD with BILLS
4 

•HR 2676 IH

1 cations the veteran stopped using because of 

2 the use of cannabis. 

3 (E) How the veteran is self-administering 

4 medicinal cannabis, including— 

5 (i) the method; 

6 (ii) the typical times each day the vet7 eran self-administers; 

8 (iii) the frequency of different prod9 ucts per day and for what condition, symp10 tom, or both; and 

11 (iv) the amounts per product. 

12 (F) The ratings and descriptions of the ef13 fectiveness of using cannabis to treat condi14 tions, symptoms, or both. 

15 (G) Any experiences with side effects. 

16 (H) The number of different cannabis 

17 products tried before settling on the current 

18 product. 

19 (I) The typical source of medical cannabis 

20 (such as a single dispensary, multiple dispensa21 ries, mail order, or other source), the typical 

22 purchase frequency, and the typical amount 

23 purchased. 

24 (J) The sources of information the veteran 

25 uses for products and dosages. 


SSpencer on DSKBBXCHB2PROD with BILLS
5 

•HR 2676 IH

1 (K) Factors that influence the choice of 

2 the veteran for using a chosen product (such as 

3 with respect to the levels of tetrahydrocannabi4 nol or cannabidiol content, cost, availability, 

5 consistency, or strain). 

6 (L) Any other matters determined appro7 priate. 

8 (2) HEALTH CARE PROVIDERS.—The survey de9 scribed in subsection (c)(2) shall cover the following 

10 subjects: 

11 (A) A description of the experience of the 

12 health care provider with respect to patients 

13 using medicinal cannabis. 

14 (B) A description by the health care pro15 vider of how medicinal cannabis is changing pa16 tients. 

17 (C) A description of how treatment plans 

18 have been modified after a veteran discloses 

19 using cannabis. 

20 (D) Any documentation of the products, 

21 dosages, or frequency of such cannabis use in 

22 the medical records of the veteran. 

23 (E) Reporting of adverse events. 

24 (F) The sources of information used by the 

25 health care provider with respect to cannabis 


SSpencer on DSKBBXCHB2PROD with BILLS
6 

•HR 2676 IH

1 products and the medical effectiveness of can2 nabis. 

3 (G) Any other matters determined appro4 priate. 

5 (e) REPORT.—Not later than one year after the date 

6 of the enactment of this Act, the Secretary shall submit 

7 to the Committees on Veterans’ Affairs of the Senate and 

8 the House of Representatives a report on the results of 

9 the surveys conducted under this section. 

Æ 


SSpencer on DSKBBXCHB2PROD with BILLS